Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Chemosphere ; 306: 135630, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-35809751

RESUMEN

Some new, highly selective, and sensitive colorimetric pH indicators, spiro[4H-indeno-[1,2-b]pyridine-4,3'-[3H]indoles] (SIPIs) in aqueous solution were developed. SIPIs were synthesized via a one-pot four-component condensation of isatin derivatives, ß-diketones 1,3-indandione, and ammonium acetate using FSi-PrNH-BuSO3H as a nanocatalyst in EtOH. According to the experimental evaluations, it was found that SIPI derivatives are pH indicators for naked-eye detection of OH- ion with intense color changes from orange to purple in the pH range of 10.3-12.


Asunto(s)
Colorimetría , Agua , Concentración de Iones de Hidrógeno , Indoles
2.
J Clin Psychopharmacol ; 39(6): 634-638, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31688396

RESUMEN

PURPOSE/BACKGROUND: This double-blind, placebo-controlled clinical trial was designed to assess the efficacy and safety of memantine augmentation to standard regimen of antipsychotic treatment on psychotic symptoms and cognitive function in individuals with chronic schizophrenia for 8 weeks. METHODS/PROCEDURES: Forty stabilized individuals with chronic schizophrenia were randomized in a 1:1 ratio to memantine (20 mg/d) and control (placebo) groups, along with their antipsychotic regimen for 8 weeks. The efficacy of treatment was assessed by the Positive and Negative Syndrome Scale (PANSS) and Brief Assessment of Cognition Scale, and the safety was measured by the Abnormal Involuntary Movement Scale and Barnes Akathisia Rating Scale at baseline and at weeks 4 and 8. FINDINGS/RESULTS: No significant differences were observed in demographic or clinical variables between both groups at baseline. During the study, all subscales and total scores of PANSS decreased significantly within both groups, except the subscale score in memantine, which was found to be positive. Reduction in general subscale and total scores of PANSS was significantly higher in the control group compared with the memantine group. All subscale scores of the Brief Assessment of Cognition Scale increased significantly only in the memantine group. The increase in the Verbal Memory, Working Memory, Verbal Fluency Letter, and Verbal Fluency Total subscale scores was significantly higher in the memantine group than in the control group. There was no significant difference in the Abnormal Involuntary Movement Scale and Barnes Akathisia Rating Scale scores between the 2 groups during the study. IMPLICATIONS/CONCLUSIONS: This study showed that adjunctive memantine to antipsychotic regimen improved the verbal memory, learning, verbal letter fluency, and working memory without improvement on psychotic symptoms in individuals with chronic schizophrenia.


Asunto(s)
Antipsicóticos/farmacología , Disfunción Cognitiva/tratamiento farmacológico , Memantina/farmacología , Nootrópicos/farmacología , Evaluación de Resultado en la Atención de Salud , Esquizofrenia/tratamiento farmacológico , Adolescente , Adulto , Anciano , Antipsicóticos/administración & dosificación , Enfermedad Crónica , Disfunción Cognitiva/etiología , Método Doble Ciego , Sinergismo Farmacológico , Quimioterapia Combinada , Femenino , Humanos , Masculino , Memantina/administración & dosificación , Persona de Mediana Edad , Nootrópicos/administración & dosificación , Esquizofrenia/complicaciones , Adulto Joven
3.
Biomed Pharmacother ; 103: 965-972, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29710513

RESUMEN

BACKGROUND AND OBJECTIVE: Today, the role of oxidative stress in development of schizophrenia has gained attention. Also, some atypical antipsychotic agents showed antioxidant properties. Therefore, in this study, we evaluated the level of oxidative stress parameters between patients treated with perphenazine, clozapine and risperidone and their relationship with schizophrenia symptoms' severity. MATERIALS AND METHODS: This was a descriptive study on 100 patients with chronic schizophrenia. Patient selection was done based on the DSM-IV-TR criteria for at least 3 months regular use of clozapine or risperidone or perphenazine and a minimum period of 2 years of schizophrenia. Ten ml of patient's blood samples were used to assess serum levels of glutathione (GSH), protein carbonyl, lipid peroxidation (LPO), superoxide dismutase (SOD) and Ferric Reducing Ability of Plasma (FRAP). Also, the severity of symptoms was assessed with the positive and negative syndrome scale (PANSS scale). P-values of less than 0.05 were considered significant. RESULTS: The results showed a significant difference between clozapine and risperidone with perphenazine in all subscales of PANSS. Also, there was a positive correlation between MDA and PANSS all subscales in risperidone and perphenazine groups and a negative correlation between MDA and PANSS in all subscales in the clozapine group. Serum level of GSH and negative symptoms in patients receiving clozapine showed a negative correlation. The results also represented that clozapine significantly increased SOD levels in comparison to perphenazine and risperidone and reduced LPO in comparison to perphenazine and risperidone, While the protein carbonyl level did not show a significant difference between three groups (p-value = 0.8). CONCLUSION: This study showed that clozapine, as an atypical antipsychotic agent, has significant antioxidant effects compared to risperidone and perphenazine. Especially, it increased SOD and GSH levels and reduced LPO in patients with schizophrenia. Therefore, clozapine's antioxidant effect may be contributive to improving negative symptoms of schizophrenic patients.


Asunto(s)
Antipsicóticos/farmacología , Clozapina/farmacología , Estrés Oxidativo/efectos de los fármacos , Perfenazina/farmacología , Risperidona/farmacología , Esquizofrenia/tratamiento farmacológico , Adolescente , Adulto , Anciano , Antipsicóticos/uso terapéutico , Biomarcadores/sangre , Clozapina/uso terapéutico , Humanos , Persona de Mediana Edad , Perfenazina/uso terapéutico , Escalas de Valoración Psiquiátrica , Risperidona/uso terapéutico , Esquizofrenia/sangre , Adulto Joven
4.
Addict Health ; 10(4): 242-249, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31263523

RESUMEN

BACKGROUND: Iranian female methadone patients are at risk of human immunodeficiency virus (HIV) due to involvement in high-risk sexual behaviours and/or needle sharing. The present study aimed to explore the perceived educational needs related to HIV among a group of Iranian female methadone patients. METHODS: The research design was qualitative and the participants were sampled purposively. Semi-structured interviews were conducted with 34 women and 19 clinicians in Sari, Mashhad, and Tehran, Iran. Then, qualitative content analysis was implemented. FINDINGS: The emergence of three major themes and six minor themes was revealed. Women expressed a need to increase their knowledge including women-specific pathophysiology and disease progression and the modes of the virus transmission and prevention. Women also expressed a need to enhance their knowledge and skills related to the physical management of the virus including self-care and reproductive health. Other themes included perceived psychosocial needs including removing stigma and access to resources in the community. CONCLUSION: Women reported a wide range of educational needs from basic knowledge to advanced skills. The findings can be used in designing women-specific educational programs related to HIV in Iran. Larger studies are suggested with gender-mixed samples in the Persian context.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...